Peri Cruiser CAR-T: An innovative platform to reduce on-target off-tumor toxicity of CAR-T therapy

被引：0
|
作者：
Zhang, Shuangshuang [1 ]
Hao, Ruidong [1 ]
Wang, Hongye [1 ]
Yi, Qiao Yong [1 ]
Li Yantao [1 ]
Zhong, Yunpeng [1 ]
Sun, Minmin [1 ]
机构：
[1] Suzhou Immunofoco Biotechnol Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2539
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Relapses After CAR-T Therapy
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (18): : 1850 - 1850
  • [42] Gut microbiome and CAR-T therapy
    Abid, Muhammad Bilal
    Shah, Nirav N.
    Maatman, Theresa C.
    Hari, Parameswaran N.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [43] Allogene and Celularity move CAR-T therapy off the shelf
    Cormac Sheridan
    Nature Biotechnology, 2018, 36 : 375 - 377
  • [44] Gut microbiome and CAR-T therapy
    Muhammad Bilal Abid
    Nirav N. Shah
    Theresa C. Maatman
    Parameswaran N. Hari
    Experimental Hematology & Oncology, 8
  • [45] The Application of Nanobody in CAR-T Therapy
    Bao, Chaolemeng
    Gao, Quanli
    Li, Lin-Lin
    Han, Lu
    Zhang, Bingxiang
    Ding, Yijin
    Song, Zongpei
    Zhang, Ruining
    Zhang, Jishuai
    Wu, Xian-Hui
    BIOMOLECULES, 2021, 11 (02) : 1 - 18
  • [46] Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity
    Meeus, Fien
    Funeh, Cyprine Neba
    Awad, Robin Maximilian
    Zeven, Katty
    Autaers, Dorien
    De Becker, Ann
    Van Riet, Ivan
    Goyvaerts, Cleo
    Tuyaerts, Sandra
    Neyns, Bart
    Devoogdt, Nick
    De Vlaeminck, Yannick
    Breckpot, Karine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [47] Overcoming Target Driven Fratricide for CAR-T Cell Therapy
    Sotiropoulou, Panagiota A.
    Breman, Eytan
    Demoulin, Benjamin
    Agaugue, Sophie
    Mauen, Sebastien
    Michaux, Alexandre
    Springuel, Lorraine
    Houssa, Julien
    Huberty, Fanny
    Jacques-Hespel, Celine
    Marchand, Celine
    Marijsse, Jerome
    Thuy Nguyen
    Ramelot, Nancy
    Daro, Dorothee
    DeWaele, Peter
    Steenwinckel, Valerie
    Gilham, David
    MOLECULAR THERAPY, 2018, 26 (05) : 57 - 58
  • [48] Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy
    Murty, Tara
    Kaczanowska, Sabina
    Alimadadi, Ahmad
    Contreras, Cristina
    Duault, Caroline
    Balasubrahmanyan, Priyanka
    Reynolds, Warren
    Gutierrez, Norma
    Baskar, Reema
    Wu, Catherine
    Michor, Franziska
    Altreuter, Jennifer
    Liu, Yang
    Jhaveri, Aashna
    Duong, Vandon
    Anbunathan, Hima
    Moravec, Radim
    Hong, Joyce
    Biswas, Roshni
    Van Nostrand, Stephen
    Lindsay, James
    Pichavant, Mina
    Sotillo, Elena
    Sahaf, Bita
    Bendall, Sean
    Maecker, Holden
    Highfill, Steven
    Stroncek, David
    Merchant, Melinda
    Glod, John
    Hedrick, Catherine
    Mackall, Crystal
    Ramakrishna, Sneha
    Kaplan, Rosandra
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Systemic tumor regression with synergy therapy: radiotherapy and CAR-T
    Ma, Xingyu
    Zhang, Wei
    Zeng, Miao
    Asavasupreechar, Teeranut
    Kang, Synat
    Li, Yisheng
    Yu, Li
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [50] CAR-T cell therapy for T cell malignances
    Watanabe, Keisuke
    CANCER SCIENCE, 2025, 116 : 1784 - 1784
12345